B

Baroness Blackwood of North Oxford (Con)

Speaking in the House of Lords on 22 July 2025

Debate

Duchenne Muscular Dystrophy: Givinostat

Contribution

My Lords, I declare my interest as chair of Genomics England and Oxford University Innovation. This product is a classic example of one that should be eligible for the innovative medicines fund. However, concerns have been raised about the clarity of entry criteria, transparency and scale of ambition. What steps are being taken to tackle those challenges in order to address the concerns raised by the noble Lord, Lord Kakkar?

More from Baroness Blackwood of North Oxford (Con)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites